Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
P16INK4a
100%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
100%
Prognostic Impact
100%
In Vitro Resistance
100%
P15INK4b
100%
Germline
60%
P16 Gene
40%
Dutch
20%
Gene Deletion
20%
Methotrexate
20%
Childhood Leukemia
20%
Leukemia Patients
20%
5-year Survival
20%
Drug Resistance
20%
Plog
20%
Fluorescence in Situ Hybridization
20%
IC50 Value
20%
P19Arf
20%
Thymidylate Synthase
20%
Disease-free Survival
20%
Methyl
20%
Multiagent Chemotherapy
20%
Drug Class
20%
Thiazol
20%
Intrinsic Resistance
20%
T-lineage ALL
20%
Inhibition Assay
20%
Complete Overlap
20%
P16 Deletion
20%
Working Diagnosis
20%
Cellular Drugs
20%
Pediatric T-cell Acute Lymphoblastic Leukemia
20%
Precursor B-cell ALL
20%
Medicine and Dentistry
In Vitro
100%
Acute Lymphoblastic Leukemia
100%
Drug Resistance
100%
P16
100%
Acute Lymphocytic Leukemia
50%
Germ Line
37%
Germ Cell
37%
Disease Free Survival
25%
Pediatrics
12%
B Cell
12%
Precursor
12%
Tumor Suppressor Gene
12%
Gene Deletion
12%
Childhood Leukemia
12%
Dexamethasone
12%
Methotrexate
12%
Fluorescence in Situ Hybridization
12%
Thymidylate Synthase
12%
Chemotherapy
12%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Drug Resistance
100%
P16
100%
Germ Cell
37%
Disease Free Survival
25%
B Cell
12%
Precursor
12%
Tumor Suppressor Gene
12%
Gene Deletion
12%
Fluorescence in Situ Hybridization
12%
Thymidylate Synthase
12%
LC50
12%
Dexamethasone
12%
Methotrexate
12%
Pediatrics
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Drug Resistance
100%
Disease Free Survival
33%
Dexamethasone
16%
Methotrexate
16%
Chemotherapy Regimens
16%
Thymidylate Synthase
16%
Childhood Leukemia
16%
Intrinsic Resistance
16%